secwatch.observer — SEC 8-K summary
======================================

Issuer:     Caribou Biosciences, Inc. (CRBU)
CIK:        0001619856
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001619856-25-000047
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Caribou Biosciences stockholders approve reverse stock split authorization at annual meeting
--------------------------------------------------------------------------------

- Class I directors elected: Scott Braunstein (40.2M votes for) and Ran Zheng (30.4M votes for).
- Deloitte & Touche ratified as independent auditor for FY2025 (66.5M for, 1.1M against).
- Amendment to charter approved to allow reverse stock split at ratio from 1:5 to 1:50, as determined by board.
- Adjournment proposal approved but unnecessary due to quorum and sufficient votes on all proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1619856/000161985625000047/0001619856-25-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1619856/000161985625000047/crbu-20250612.htm
  HTML page:      https://secwatch.observer/filing/0001619856-25-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer